Elmet Group (ELMT), a U.S. defense supplier that went public in April, is testing its latest buy point as market volatility puts pressure on newly listed stocks. The company reported fiscal second-quarter revenue of $66.4 million, up 35% year over year. The revenue growth offers one measure of its recent business performance; whether the stock can hold a breakout level is a separate question. No specific share price or breakout magnitude was provided.
Elmet supplies aerospace, defense and industrial markets
Headquartered in Portland, Maine, Elmet sells tungsten heavy alloys, molybdenum plate and thermal-shield materials, along with precision-engineered components and high-energy systems. Its products serve aerospace, defense, medical and industrial applications.
Elmet materials and components are used in rocket engines, tactical missile systems, submarines, radar-tracking platforms and other military vehicles and equipment. Its products are also used in Lockheed Martin’s F-35 fighter jet, linking the business to major aerospace and defense supply chains. The available information does not specify the revenue share or contract value associated with these products.
Fiscal second-quarter revenue climbed 35%
Elmet reported revenue of $66.4 million for the second quarter of fiscal 2026, a 35% increase from the same period a year earlier. The figure provides a recent snapshot of sales growth, but no profit, cash-flow or full-year guidance figures were disclosed. Revenue growth alone therefore does not show whether the company is profitable or how its business may perform in subsequent quarters.
Volatility puts the attempted breakout in focus
Since its April IPO, Elmet has been included on the IPO Leaders watchlist. The stock is attempting to move above its latest buy point, but volatile market conditions have made breakouts harder to assess: chart patterns that appear to form can later fall below key levels and trigger stop-loss orders.
No closing share price, buy-point level or confirmation of a breakout was provided, leaving the stock’s move to be assessed against subsequent trading data. Elmet’s short public-market history also makes it important to distinguish reported operating results from price signals: the 35% revenue increase is a disclosed financial measure, while the stock’s ability to hold above its buy point remains unconfirmed. The available information does not provide further details on orders, customer concentration or earnings expectations.